#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16628	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2171	756.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1409	1409	C	931	C,A	906,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30470	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3737	811.1	0	.	n	.	0	T695C	SNP	695	695	T	1160	1160	C	863	C,G	846,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30470	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3737	811.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1802	1802	A	1016	A,G	991,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30470	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3737	811.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2436	2436	C	938	C,T,A	910,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30470	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3737	811.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2510	2510	A	944	A	929	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30470	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3737	811.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3062	3062	C	1016	C,T,A	976,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30470	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3737	811.1	0	HET	.	.	.	C709T	.	709	709	C	1174	1174	C	878	C,T	696,169	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	V36A	NONSYN	106	108	GTG	403	405	GCG	159;159;161	G;C;G	155;156;157	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	445	447	CGG	157;156;155	C,G;G;G	146,1;148;149	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	S68L	NONSYN	202	204	TCG	499	501	TTG	138;140;139	T;T;G	125;137;135	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	A90V	NONSYN	268	270	GCG	565	567	GTT	149;148;147	G;T;T,C	142;132;137,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	I105V	NONSYN	313	315	ATT	610	612	GTT	160;159;160	G;T,G;T,C	157;142,1;155,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	N125T	NONSYN	373	375	AAT	670	672	ACC	155;155;152	A,G;C;C	142,1;144;146	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	R135C	NONSYN	403	405	CGT	700	702	TGT	161;158;156	T;G;T,G	145;150;139,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	K151E	NONSYN	451	453	AAA	748	750	GAA	145;146;146	G;A;A	143;144;145	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	T152N	NONSYN	454	456	ACC	751	753	AAC	148;149;148	A;A;C	147;145;147	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	A172T	NONSYN	514	516	GCG	811	813	ACA	144;146;147	A;C;A	142;145;145	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	A175E	NONSYN	523	525	GCG	820	822	GAA	146;150;153	G,A;A;A	139,1;145;147	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	E176T	NONSYN	526	528	GAA	823	825	ACC	155;158;160	A;C;C	144;150;154	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	I178V	NONSYN	532	534	ATC	829	831	GTC	157;158;156	G;T;C	151;150;148	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	I188T	NONSYN	562	564	ATA	859	861	ACG	155;156;158	A;C;G	146;150;149	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	P200N	NONSYN	598	600	CCC	895	897	AAC	139;142;140	A;A;C	134;138;137	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	F220L	NONSYN	658	660	TTT	955	957	TTG	146;144;145	T;T;G	144;143;140	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1012	1014	ACC	151;151;150	A;C;C	149;150;150	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1015	1017	GAC	150;150;152	G;A;C	149;144;151	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1024	1026	GCG	150;151;150	G;C;G	149;121;146	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1060	1062	GCT	141;142;143	G,A;C,G;T	133,1;131,1;123	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1552	folP	858	858	91.61	folP.l15.c4.ctg.1	1555	99.3	1	SNP	p	R230S	1	.	.	688	690	AGC	985	987	AGC	174;174;174	A;G;C	168;172;172	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5378	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3328	160.3	1	SNP	p	S91F	0	.	.	271	273	TCC	605	607	TCC	204;205;206	T;C;C	195;198;200	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5378	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3328	160.3	1	SNP	p	D95G	0	.	.	283	285	GAC	617	619	GAC	210;211;210	G;A;C	200;203;203	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5378	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3328	160.3	1	SNP	p	D95N	0	.	.	283	285	GAC	617	619	GAC	210;211;210	G;A;C	200;203;203	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1680	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1425	117.3	1	SNP	p	G45D	1	.	.	133	135	GAC	561	563	GAC	202;202;202	G,C;A;C	196,1;196;198	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	934	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c4.ctg.1	1134	81.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4806	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2920	163.6	1	SNP	p	D86N	0	.	.	256	258	GAC	577	579	GAC	184;183;184	G;A;C	180;177;179	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4806	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2920	163.6	1	SNP	p	S87R	0	.	.	259	261	AGT	580	582	AGT	182;183;185	A;G;T	178;180;176	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4806	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2920	163.6	1	SNP	p	S87I	0	.	.	259	261	AGT	580	582	AGT	182;183;185	A;G;T	178;180;176	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4806	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2920	163.6	1	SNP	p	S87W	0	.	.	259	261	AGT	580	582	AGT	182;183;185	A;G;T	178;180;176	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4806	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2920	163.6	1	SNP	p	S88P	0	.	.	262	264	TCC	583	585	TCC	187;189;188	T,A;C,A;C	179,1;180,1;184	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3934	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2715	143.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1533	1535	GGC	191;187;183	G,A;G;C	185,1;182;174	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	166.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1266	1268	GCC	202;202;202	G;C,T;C	196;197,1;197	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	166.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1269	1271	ATG	200;202;202	A;T;G	196;197;195	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	166.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1281	1283	ACC	209;206;207	A;C;C	199;201;200	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	166.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1281	1283	ACC	209;206;207	A;C;C	199;201;200	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	166.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1782	1784	ACC	197;198;201	A;C;C,G	191;196;199,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	166.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1836	1838	GCG	171;171;171	G;C;G	166;163;165	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	166.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1836	1838	GCG	171;171;171	G;C;G	166;163;165	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	166.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1959	1961	GGT	139;137;134	G;G;T,C	136;134;129,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	166.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1968	1970	AGC	127;125;125	A,G;G;C	117,1;120;119	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	166.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1986	1988	CCG	111;113;115	C,G;C,G;G,C	100,4;101,2;96,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5382	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3228	165.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2402	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1882	126.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	608	608	C	163	C	152	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	295	90.64	porB1a.l6.c17.ctg.1	1231	22.8	0	.	p	.	0	H217N	NONSYN	649	651	CAT	961	963	AAT	26;26;26	A;A;T	26;26;26	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	295	90.64	porB1a.l6.c17.ctg.1	1231	22.8	0	.	p	.	0	D218N	NONSYN	652	654	GAT	964	966	AAT	26;25;25	A;A;T	26;25;25	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	295	90.64	porB1a.l6.c17.ctg.1	1231	22.8	0	.	p	.	0	V226A	NONSYN	676	678	GTA	988	990	GCA	19;19;19	G;C;A	19;19;19	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	295	90.64	porB1a.l6.c17.ctg.1	1231	22.8	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1011	1013	GTA	17;17;17	G;T;A	17;17;17	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	295	90.64	porB1a.l6.c17.ctg.1	1231	22.8	0	.	p	.	0	S236N	NONSYN	706	708	AGC	1017	1019	AAC	16;16;16	A;A;C	16;16;16	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	295	90.64	porB1a.l6.c17.ctg.1	1231	22.8	0	.	p	.	0	N237M	NONSYN	709	711	AAC	1020	1022	ATG	16;16;16	A;T;G	16;16;16	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	310	porB1a	984	295	90.64	porB1a.l6.c17.ctg.1	1231	22.8	0	.	p	.	0	D238fs	FSHIFT	712	712	G	1023	1023	G	17	G	17	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2592	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1558	164.5	0	.	p	.	0	E41K	NONSYN	121	123	GAA	421	423	AAA	186;185;185	A,C;A;A	182,1;183;182	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2592	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1558	164.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	931	931	T	227	T	217	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2592	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1558	164.5	1	SNP	p	G120K	0	.	.	358	360	GGT	658	660	GGT	207;207;207	G;G,A;T,A	196;197,1;188,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2592	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1558	164.5	1	SNP	p	A121N	0	.	.	361	363	GCC	661	663	GCC	208;206;206	G;C;C	196;195;197	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2592	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1558	164.5	1	SNP	p	A121D	0	.	.	361	363	GCC	661	663	GCC	208;206;206	G;C;C	196;195;197	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9132	rpoB	4179	4179	100.0	rpoB.l6.c30.ctg.1	4876	186.1	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2030	2032	CAT	207;206;205	C,A,T;A;T	200,1,1;200;197	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1072	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1059	100.3	1	SNP	p	V57M	1	.	.	169	171	ATG	518	520	ATG	209;207;206	A;T;G,A	203;199;198,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
